Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply.
Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, Shimmura S, Kruse FE. Deng SX, et al. Among authors: dana r. Cornea. 2019 Dec;38(12):e56-e57. doi: 10.1097/ICO.0000000000002145. Cornea. 2019. PMID: 31517726 Free PMC article. No abstract available.
TFOS DEWS II Management and Therapy Report.
Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, Seo KY, Tauber J, Wakamatsu TH, Xu J, Wolffsohn JS, Craig JP. Jones L, et al. Among authors: dana r. Ocul Surf. 2017 Jul;15(3):575-628. doi: 10.1016/j.jtos.2017.05.006. Epub 2017 Jul 20. Ocul Surf. 2017. PMID: 28736343 Review.
Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.
Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, Foster CS, Affeldt J, Seedor JA, Afshari NA, Chao W, Allegretti M, Mantelli F, Dana R. Pflugfelder SC, et al. Among authors: dana r. Ophthalmology. 2020 Jan;127(1):14-26. doi: 10.1016/j.ophtha.2019.08.020. Epub 2019 Aug 26. Ophthalmology. 2020. PMID: 31585826 Free article. Clinical Trial.
Global Consensus on the Management of Limbal Stem Cell Deficiency.
Deng SX, Kruse F, Gomes JAP, Chan CC, Daya S, Dana R, Figueiredo FC, Kinoshita S, Rama P, Sangwan V, Slomovic AR, Tan D; and the International Limbal Stem Cell Deficiency Working Group. Deng SX, et al. Among authors: dana r. Cornea. 2020 Oct;39(10):1291-1302. doi: 10.1097/ICO.0000000000002358. Cornea. 2020. PMID: 32639314
Defining Dry Eye from a Clinical Perspective.
Tsubota K, Pflugfelder SC, Liu Z, Baudouin C, Kim HM, Messmer EM, Kruse F, Liang L, Carreno-Galeano JT, Rolando M, Yokoi N, Kinoshita S, Dana R. Tsubota K, et al. Among authors: dana r. Int J Mol Sci. 2020 Dec 4;21(23):9271. doi: 10.3390/ijms21239271. Int J Mol Sci. 2020. PMID: 33291796 Free PMC article. Review.
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial.
Dohlman TH, McSoley M, Amparo F, Carreno-Galeano T, Wang M, Dastjerdi M, Singh RB, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Gomes JAP, Perez VL, Yin J, Dana R. Dohlman TH, et al. Among authors: dana r. Ophthalmology. 2022 Aug;129(8):865-879. doi: 10.1016/j.ophtha.2022.03.024. Epub 2022 Mar 28. Ophthalmology. 2022. PMID: 35358592 Free PMC article. Clinical Trial.
Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.
Dohlman TH, Singh RB, Amparo F, Carreno-Galeano T, Dastjerdi M, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Saeed H, Gomes JAP, Perez VL, Yin J, Dana R. Dohlman TH, et al. Among authors: dana r. Ophthalmol Sci. 2024 Feb 13;4(4):100492. doi: 10.1016/j.xops.2024.100492. eCollection 2024 Jul-Aug. Ophthalmol Sci. 2024. PMID: 38682029 Free PMC article.
516 results